In a recent report published by J.P. Morgan, they are raising the EPS from $1.10 to $1.25 and Price Target from $26.00 to $28.00 on HealthSouth Corp HLS following 1Q11 report.
In the report, J.P. Morgan cites, “Revenue was above our view by $8mm (about 1.5%) as outpatient pricing came in above our outlook and volumes were better than expected. Adjusted EBITDA in the quarter was $123.4mm, $9.3mm (8.1%) above our outlook. Against our outlook all expense lines came in better than our outlook with salaries and benefits (70bps), bad debt (40bps), G&A (30bps), and other op expense and supplies each 10bps better than our view.”
HealthSouth Corp closed Friday at $25.63.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in